Sebastian Ueckert

8PUBLICATIONS
17CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 09, 2026
RNA interference therapy targeting coagulation factor XI: a first-in-human trial of RBD4059 (vortosiran).

Anders Gabrielsen, Sebastian Ueckert, Catarina Nilsson

|Nov 05, 2025
Predictors of Ability to Work in Multiple Sclerosis.

Gustaf J Wellhagen, Sebastian Ueckert, Elisabet Nielsen

|Jul 24, 2024
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approach.

Hongtao Yu, Sebastian Ueckert, Lina Zhou

|Jul 04, 2024
From Plan to Pivot: How Model-Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH Trials.

Anne-Kristina Mercier, Sebastian Ueckert, Mikael Sunnåker

|Sep 26, 2023
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.

Jane Knöchel, Linnéa Bergenholm, Eman Ibrahim

|Sep 19, 2023
Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migraine.

Po-Wei Chen, Mats O Karlsson, Sebastian Ueckert

Pageof 2